Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Protein orai-1 | 0.9118 | 1 | 1 |
Schistosoma mansoni | Protein orai-1 | 0.9118 | 1 | 1 |
Echinococcus multilocularis | calcium release activated calcium channel | 0.9118 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.9118 | 1 | 1 |
Echinococcus granulosus | calcium release activated calcium channel | 0.9118 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Transactivation of full-length RXRgamma (unknown origin) expressed in African green monkey COS1 cells at 1000 nM by luciferase reporter gene assay | ChEMBL. | 23685180 | |
Activity (binding) | Transactivation of full-length RXRalpha (unknown origin) expressed in African green monkey COS1 cells at 1000 nM by luciferase reporter gene assay | ChEMBL. | 23685180 | |
Activity (binding) | Transactivation of full-length RXRbeta (unknown origin) expressed in African green monkey COS1 cells at 1000 nM by luciferase reporter gene assay | ChEMBL. | 23685180 | |
FC (binding) | = 1 | Transactivation of Gal4-fused RARbeta (unknown origin) expressed in African green monkey COS1 cells at 100 nM by luciferase reporter gene assay relative to DMSO-treated control | ChEMBL. | 23685180 |
FC (binding) | = 2 | Transactivation of Gal4-fused RARgamma (unknown origin) expressed in African green monkey COS1 cells at 100 nM by luciferase reporter gene assay relative to DMSO-treated control | ChEMBL. | 23685180 |
FC (binding) | = 43 | Transactivation of Gal4-fused RARalpha (unknown origin) expressed in African green monkey COS1 cells at 100 nM by luciferase reporter gene assay relative to DMSO-treated control | ChEMBL. | 23685180 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.